You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis C Genotype 3

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis C Trial in Bradford, London, Nottingham (Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin)

Completed
  • Hepatitis C
  • Bradford, United Kingdom
  • +3 more
Jan 4, 2023

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus Infection
  • (no location specified)
Jul 8, 2021

Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)

Completed
  • Chronic Hepatitis c Genotype 1
  • Moscow, Russian Federation
  • +4 more
Oct 27, 2022

Hepatitis C, HCV Trial in San Antonio (TD-6450, Placebo)

Completed
  • Hepatitis C
  • HCV
  • San Antonio, Texas
    Texas Liver Institute
Jan 15, 2021

Hepatitis C Virus Trial in Korea, Republic of, Russian Federation, Taiwan (DCV/ASV/BMS-791325)

Completed
Has Results
  • Hepatitis C Virus
  • Busan, Korea, Republic of
  • +19 more
Oct 27, 2020

Zepatier in Patients With Substance Use

Active, not recruiting
  • Hepatitis C
  • +3 more
  • Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
  • Chicago, Illinois
    University of Illinois at Chicago
Jun 28, 2022

Chronic Hepatitis C Virus Infection Trial in China, Korea, Republic of, Taiwan (P1101 + Ribavirin, PEG-Intron + Ribavirin)

Completed
  • Chronic Hepatitis C Virus Infection
  • P1101 + Ribavirin
  • PEG-Intron + Ribavirin
  • Beijing, China
  • +38 more
Jan 14, 2022

Chronic Hepatitis C Virus, Hepatitis C Virus Trial (ABT-493/ABT-530, sofosbuvir (SOF), ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus
  • Hepatitis C Virus
  • (no location specified)
Jul 14, 2021

Hepatitis C Infection, Hepatitis C Virus Trial (ombitasvir/paritaprevir/ritonavir, dasabuvir)

Completed
Has Results
  • Hepatitis C Infection
  • Hepatitis C Virus
  • (no location specified)
Jul 28, 2021

Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493/ABT-530)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

Completed
Has Results
  • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
  • Phoenix, Arizona
  • +47 more
Jun 27, 2022

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Hepatitis C, Cirrhosis Trial (Sofosbuvir/Velpatasvir + Ribavirin, Sofosbuvir/Velpatasvir/Voxilaprevir)

    Not yet recruiting
    • Hepatitis C
    • Cirrhosis
    • (no location specified)
    Jul 20, 2022

    Chronic Hepatitis C Virus (HCV) Infection Trial (ABT-493/ABT-530, Placebo for ABT-493/ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C Virus (HCV) Infection
    • (no location specified)
    Jul 14, 2021

    Hepatitis C Virus Infection, Chronic Hepatitis C, Compensated Cirrhosis Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +2 more
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Infection, Compensated Cirrhosis Trial (Ombitasvir/Paritaprevir/Ritonavir, Dasabuvir)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • Compensated Cirrhosis
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C, Hepatitis C Virus, HCV Trial (ABT-493, ABT-530)

    Completed
    Has Results
    • Chronic Hepatitis C
    • +2 more
    • (no location specified)
    Jul 9, 2021

    HCV Trial in Beijing (Ravidasvir, Danoprevir, Ritonavir)

    Completed
    • HCV
    • Beijing, Beijing, China
      Peking University People's hospital
    Jul 25, 2020

    Hepatitis C Virus Trial (ABT-493/ABT-530)

    Completed
    Has Results
    • Hepatitis C Virus
    • (no location specified)
    Jul 9, 2021

    Hepatitis C Virus Infection, Human Immunodeficiency Virus Infection, Chronic Hepatitis C Trial (ABT-493 coformulated with

    Completed
    Has Results
    • Hepatitis C Virus Infection
    • +3 more
    • ABT-493 coformulated with ABT-530
    • (no location specified)
    Jul 9, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for Ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ribavirin)

    Completed
    Has Results
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +2 more
    • (no location specified)
    Jul 8, 2021

    Hepatitis C, Chronic Trial in Taiwan (P1101 + Ribavirin)

    Recruiting
    • Hepatitis C, Chronic
    • P1101 + Ribavirin
    • Chiayi City, Taiwan
    • +7 more
    Jun 30, 2022

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    Has Results
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021